Ensign Peak Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $13.8M | Sell |
|
|||||
|
2023
Q1 | $8.38M | Hold |
|
|||||
|
2022
Q4 | $9.48M | Buy |
|
|||||
|
2022
Q3 | $4.66M | Buy |
|
|||||
|
2022
Q2 | $3.25M | Hold |
|
|||||
|
2022
Q1 | $3.04M | Hold |
|
|||||
|
2021
Q4 | $3.04M | Buy |
|
|||||
|
2021
Q3 | $1.31M | Hold |
|
|||||
|
2021
Q2 | $1.46M | Hold |
|
|||||
|
2021
Q1 | $1.6M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Hold |
|
|||||
|
2020
Q3 | $845K | Buy |
|
|||||
|
2020
Q2 | $209K | Buy |
|